Heart fatty acid binding protein and myoglobin after reperfusion of acute myocardial infarction

Acta Cardiologica

Volumn 62, Issue 5, 2007, Pages 473-478

  Özdemir, Murat ^a   Durakoǧlugil, Emre ^a   Gülbahar, Özlem ^a   Turkoglu, Sedat ^a   Sancak, Banu ^a   Paşaoǧlu, Hatice ^a   Çengel, Atiye ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Biomarkers; Myocardial infarction; Reperfusion

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; MYOGLOBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART INFARCTION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION;

ACUTE DISEASE; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; MYOGLOBIN; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 35348819320     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.62.5.2023410     Document Type: Article

References (19)

1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Jr., Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82-292.
2. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.
3. Azzazy HM, Pelsers MM, Christenson RH. Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications. Clin Chem 2006; 52: 19-29.
4. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005; 352: 15-35.
5. Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H, Iwase M, Kondo T, Nomura M, Nagamura Y, Watanabe Y, Hishida H, Tanaka T, Kawamura K. Serum concentrations of myoglobin vs. human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997; 43: 1372-8.
6. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, Nishimura S, Ishii H, Sunahara N, Tanaka T. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000; 38: 231-8.
7. Seino Y, Tomita Y, Takano T, Ohbayashi K. Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. Circ J 2004; 68: 144-8.
8. Haastrup B, Gill S, Kristensen SR, Jorgensen PJ, Glatz JF, Haghfelt T, Horder M. Biochemical markers of ischaemia for the early identification of acute myocardial infarction without ST segment elevation. Cardiology 2000; 94: 254-61.
9. Chan CP, Sanderson JE, Glatz JF, Cheng WS, Hempel A, Renneberg R. A superior early myocardial infarction marker. Human heart-type fatty acid-binding protein. Z Kardiol 2004; 93: 388-97.
10. Wodzig KW, Kragten JA, Modrzejewski W, Gorski J, van Dieijen-Visser MP, Glatz JF, Hermens WT. Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins. Clin Chim Acta 1998; 272: 209-23.
11. Alhadi HA, Fox KA. Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. QJM 2004; 97: 187-98.
12. Rajappa M, Sharma A. Biomarkers of cardiac injury: an update. Angiology 2005; 56: 677-91.
13. Christenson RH, Ohman EM, Topol EJ, Peck S, Newby LK, Duh SH, Kereiakes DJ, Worley SJ, Alosozana GL, Wall TC, Califf RM. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7. Circulation 1997; 96: 1776-82.
14. Stewart JT, French JK, Theroux P, Ramanathan K, Solymoss BC, Johnson R, White HD. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol 1998; 31: 1499-505.
15. Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. J Am Coll Cardiol 1999; 34: 739-47.
16. Laperche T, Steg PG, Benessiano J, Dehoux M, Juliard JM, Himbert D, Gourgon R. Patterns of myoglobin and MM creatine kinase isoforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implications for the early noninvasive diagnosis of reperfusion. Am J Cardiol 1992; 70: 1129-34.
17. de Groot MJ, Muijtjens AM, Simoons ML, Hermens WT, Glatz JF. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma. Heart 2001; 85: 278-85.
18. de Lemos JA, Antman EM, Morrow DA, Llevadot J, Giugliano RP, Coulter SA, Schuhwerk KC, Arslanian S, McCabe CH, Gibson CM, Rifai N. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta 2000; 298: 85-97.
19. Ishii J, Nagamura Y, Nomura M, Wang JH, Taga S, Kinoshita M, Kurokawa H, Iwase M, Kondo T, Watanabe Y, Hishida H, Tanaka T, Kawamura K. Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid-binding protein. Clin Chim Acta 1997; 262: 13-27.